CCM-SRX

N/A

Report date: 2025/06/11 10:54:57
NME

Base Information

Drug NameCCM-SRX
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-3, mitochondrial agonists
TargetsNAD-dependent protein deacetylase sirtuin-3, mitochondrial
Therapy Area/IndicationsInfertilityAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCCM Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCCM Biosciences Inc
Inactive CompaniesN/A
Active IndicationsInfertilityAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A